EMDB-71680:
Closed-state structure of wild-type human TRPV3 purified in GDN detergent
Method: single particle / : Purohit R, Khau J, Nadezhdin KD, Sobolevsky AI

EMDB-71681:
Inactivated-state structure of wild-type human TRPV3 purified in GDN detergent
Method: single particle / : Purohit R, Khau J, Nadezhdin KD, Sobolevsky AI

EMDB-77134:
Structure of human TRPV3-G568C Olmsted syndrome mutant in the closed state
Method: single particle / : Khau J, Purohit R, Nadezhdin KD, Sobolevsky AI

EMDB-77135:
Structure of human TRPV3-G568C Olmsted syndrome mutant in the open state
Method: single particle / : Khau J, Purohit R, Nadezhdin KD, Sobolevsky AI

EMDB-77137:
Structure of human TRPV3-Q580P Olmsted syndrome mutant in the open state
Method: single particle / : Khau J, Purohit R, Nadezhdin KD, Sobolevsky AI

EMDB-77138:
Structure of human TRPV3-Q580P Olmsted syndrome mutant in the inactivated state
Method: single particle / : Purohit R, Khau J, Nadezhdin KD, Sobolevsky AI

EMDB-77139:
Structure of human TRPV3-W692G Olmsted syndrome mutant in the open state
Method: single particle / : Nadezhdin KD, Khau J, Purohit R, Sobolevsky AI

EMDB-77140:
Structure of human TRPV3-W692G Olmsted syndrome mutant in the inactivated state
Method: single particle / : Nadezhdin KD, Khau J, Purohit R, Sobolevsky AI

EMDB-77141:
Structure of human TRPV3-G568D Olmsted syndrome mutant in the 4-fold symmetrical open state
Method: single particle / : Nadezhdin KD, Purohit R, Khau J, Sobolevsky AI

EMDB-77142:
Structure of human TRPV3-G568D Olmsted syndrome mutant in the 4-fold symmetrical inactivated state
Method: single particle / : Nadezhdin KD, Khau J, Purohit R, Sobolevsky AI

EMDB-77143:
Structure of human TRPV3-G568D Olmsted syndrome mutant in the 2-fold symmetrical closed state
Method: single particle / : Nadezhdin KD, Purohit R, Khau J, Sobolevsky AI

EMDB-77144:
Structure of human TRPV3-G568D Olmsted syndrome mutant in the 2-fold symmetrical open state
Method: single particle / : Nadezhdin KD, Khau J, Purohit R, Sobolevsky AI

EMDB-77145:
Structure of human TRPV3-W521S Olmsted syndrome mutant in the closed state
Method: single particle / : Nadezhdin KD, Khau J, Purohit R, Sobolevsky AI

EMDB-76261:
Spermine-blocked open-state cryo-EM structure of human TRPV6 channel in cNW30 nanodiscs
Method: single particle / : Neuberger A, Sobolevsky AI

EMDB-70909:
Heteromeric GluA1/A2 in the inactive state, consensus refinement of LBD-TMD
Method: single particle / : Yen LY, Newton TP, Gangwar SP, Sobolevsky AI

EMDB-70910:
Heteromeric GluA1/A2 in the inactive state, transmembrane domain (TMD)
Method: single particle / : Yen LY, Newton TP, Gangwar SP, Sobolevsky AI

EMDB-70911:
Heteromeric GluA1/A2 in the inactive state, ligand binding domain (LBD)
Method: single particle / : Yen LY, Newton TP, Gangwar SP, Sobolevsky AI

EMDB-70912:
Heteromeric GluA1/A2 in the inactive state, composite map of LBD-TMD
Method: single particle / : Yen LY, Sobolevsky AI, Newton TP, Gangwar SP

EMDB-70913:
Heteromeric GluA1/A2 in the activated state, consensus refinement of ATD-LBD-TMD
Method: single particle / : Yen LY, Newton TP, Gangwar SP, Sobolevsky AI

EMDB-70914:
Heteromeric GluA1/A2 in the activated state, ligand binding domain (LBD)
Method: single particle / : Yen LY, Newton TP, Gangwar SP, Sobolevsky AI

EMDB-70915:
Heteromeric GluA1/A2 in the activated state, transmembrane domain (TMD)
Method: single particle / : Yen LY, Newton TP, Gangwar SP, Sobolevsky AI

EMDB-70916:
Heteromeric GluA1/A2-CNIH1 in the activated state, consensus refinement of LBD-TMD
Method: single particle / : Yen LY, Newton TP, Gangwar SP, Sobolevsky AI

EMDB-70917:
Heteromeric GluA1/A2-CNIH1 in the activated state, ligand binding domain (LBD)
Method: single particle / : Yen LY, Newton TP, Gangwar SP, Sobolevsky AI

EMDB-70918:
Heteromeric GluA1/A2-CNIH1 in the activated state, transmembrane domain (TMD)
Method: single particle / : Yen LY, Newton TP, Gangwar SP, Sobolevsky AI

EMDB-70919:
Composite map of GluA1/A2 in the activated state, in complex with positive allosteric modulator (R,R)-2b and agonist glutamate (ATD-LBD-TMD)
Method: single particle / : Yen LY, Sobolevsky AI, Newton TP, Gangwar SP

EMDB-70920:
Heteromeric GluA1/A2-CNIH1 in the activated state, composite map of LBD-TMD
Method: single particle / : Yen LY, Newton TP, Gangwar SP, Sobolevsky AI

EMDB-70921:
Heteromeric GluA1/A2 in the desensitized state, consensus refinement of ATD-LBD-TMD
Method: single particle / : Yen LY, Newton TP, Gangwar SP, Sobolevsky AI

EMDB-70922:
Heteromeric GluA1/A2 in the desensitized state, amino-terminal domain (ATD)
Method: single particle / : Yen LY, Newton TP, Gangwar SP, Sobolevsky AI

EMDB-70923:
Heteromeric GluA1/A2 in the desensitized state, ligand binding domain (LBD)
Method: single particle / : Yen LY, Newton TP, Gangwar SP, Sobolevsky AI

EMDB-70924:
Heteromeric GluA1/A2 in the desensitized state, transmembrane domain (TMD)
Method: single particle / : Yen LY, Newton TP, Gangwar SP, Sobolevsky AI

EMDB-70925:
Heteromeric GluA1/A2 in the desensitized state, composite map of ATD-LBD-TMD
Method: single particle / : Yen LY, Newton TP, Gangwar SP, Sobolevsky AI

EMDB-75274:
Heteromeric GluA1/A2 in the activated state, amino-terminal domain (ATD)
Method: single particle / : Yen LY, Newton TP, Gangwar SP, Sobolevsky AI

EMDB-49625:
Structure of human annexin A1 in complex with 2C1 Fab
Method: single particle / : Nadezhdin KD, Sobolevsky AI

EMDB-48892:
Ligand-binding and transmembrane domains for GluK2-0xNeto2 in the open state, in complex with the positive allosteric modulator BPAM344 and agonist kainate
Method: single particle / : Gangwar SP, Yelshanskaya MV, Yen LY, Newton TP, Sobolevsky AI

EMDB-49067:
Consensus map for GluK2 in the open state, in complex with the positive allosteric modulator BPAM344 and agonist kainate
Method: single particle / : Gangwar SP, Yelshanskaya MV, Yen LY, Newton TP, Sobolevsky AI

EMDB-49073:
Consensus map for GluK2-2xNeto2 in the open state, in complex with the positive allosteric modulator BPAM344 and agonist kainate
Method: single particle / : Gangwar SP, Yelshanskaya MV, Yen LY, Newton TP, Sobolevsky AI

EMDB-48894:
Ligand-binding and transmembrane domains for GluK2-1xNeto2 in the open state, in complex with the positive allosteric modulator BPAM344 and agonist kainate
Method: single particle / : Gangwar SP, Yelshanskaya MV, Yen LY, Newton TP, Sobolevsky AI

EMDB-48882:
Amino-terminal domain for GluK2 in the open state, in complex with the positive allosteric modulator BPAM344 and agonist kainate
Method: single particle / : Gangwar SP, Yelshanskaya MV, Yen LY, Newton TP, Sobolevsky AI

EMDB-49071:
Consensus map for GluK2-0xNeto2 in the open state, in complex with the positive allosteric modulator BPAM344 and agonist kainate
Method: single particle / : Gangwar SP, Yelshanskaya MV, Yen LY, Newton TP, Sobolevsky AI

EMDB-48884:
Ligand-binding and transmembrane domains for GluK2 in the open state, in complex with the positive allosteric modulator BPAM344 and agonist kainate
Method: single particle / : Gangwar SP, Yelshanskaya MV, Yen LY, Newton TP, Sobolevsky AI

EMDB-48885:
Amino-terminal domain for GluK2-0xNeto2 in the apo state with asymmetric ligand binding domain
Method: single particle / : Gangwar SP, Yelshanskaya MV, Yen LY, Newton TP, Sobolevsky AI

EMDB-48886:
Ligand-binding and transmembrane domains for GluK2-0xNeto2 in the apo state with asymmetric ligand binding domain
Method: single particle / : Gangwar SP, Yelshanskaya MV, Yen LY, Newton TP, Sobolevsky AI

EMDB-48893:
Amino-terminal domain for GluK2-1xNeto2 in the open state, in complex with the positive allosteric modulator BPAM344 and agonist kainate
Method: single particle / : Gangwar SP, Yelshanskaya MV, Yen LY, Newton TP, Sobolevsky AI

EMDB-49068:
Consensus map for GluK2-0xNeto2 in the apo state with asymmetric ligand-binding domain
Method: single particle / : Gangwar SP, Yelshanskaya MV, Yen LY, Newton TP, Sobolevsky AI

EMDB-48895:
Amino-terminal domain for GluK2-2xNeto2 in the open state, in complex with the positive allosteric modulator BPAM344 and agonist kainate
Method: single particle / : Gangwar SP, Yelshanskaya MV, Yen LY, Newton TP, Sobolevsky AI

EMDB-48896:
Ligand-binding and transmembrane domains for GluK2-2xNeto2 in the open state, in complex with the positive allosteric modulator BPAM344 and agonist kainate
Method: single particle / : Gangwar SP, Yelshanskaya MV, Yen LY, Newton TP, Sobolevsky AI

EMDB-48891:
Amino-terminal domain for GluK2-0xNeto2 in the open state, in complex with the positive allosteric modulator BPAM344 and agonist kainate
Method: single particle / : Gangwar SP, Yelshanskaya MV, Yen LY, Newton TP, Sobolevsky AI

EMDB-49072:
Consensus map for GluK2-1xNeto2 in the open state, in complex with the positive allosteric modulator BPAM344 and agonist kainate
Method: single particle / : Gangwar SP, Yelshanskaya MV, Yen LY, Newton TP, Sobolevsky AI

EMDB-47792:
Structure of full length AMPA receptor GluA2 and auxiliary subunit TARP gamma-2 in complex with anti-miR 17 oligonucleotide RGLS4326
Method: single particle / : Yen LY, Gangwar SP, Yelshanskaya MV, Sobolevsky AI

EMDB-47793:
Structure of AMPA receptor GluA2 and auxiliary subunit TARP gamma-2 (LBD-TMD) in complex with anti-miR 17 oligonucleotide RGLS4326
Method: single particle / : Yen LY, Gangwar SP, Yelshanskaya MV, Sobolevsky AI